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Abstract
We have shown that cystic fibrosis transmembrane conductance regulator (CFTR) is involved in ATP release from skeletal
muscle at low pH. These experiments investigate the signal transduction mechanism linking pH depression to CFTR
activation and ATP release, and evaluate whether CFTR is involved in ATP release from contracting muscle. Lactic acid
treatment elevated interstitial ATP of buffer-perfused muscle and extracellular ATP of L6 myocytes: this ATP release was
abolished by the non-specific CFTR inhibitor, glibenclamide, or the specific CFTR inhibitor, CFTRinh-172, suggesting that
CFTR was involved, and by inhibition of lactic acid entry to cells, indicating that intracellular pH depression was required.
Muscle contractions significantly elevated interstitial ATP, but CFTRinh-172 abolished the increase. The cAMP/PKA pathway
was involved in the signal transduction pathway for CFTR-regulated ATP release from muscle: forskolin increased CFTR
phosphorylation and stimulated ATP release from muscle or myocytes; lactic acid increased intracellular cAMP, pCREB and
PKA activity, whereas IBMX enhanced ATP release from myocytes. Inhibition of PKA with KT5720 abolished lactic-acid- or
contraction-induced ATP release from muscle. Inhibition of either the Na+/H+-exchanger (NHE) with amiloride or the Na+/
Ca2+-exchanger (NCX) with SN6 or KB-R7943 abolished lactic-acid- or contraction-induced release of ATP from muscle,
suggesting that these exchange proteins may be involved in the activation of CFTR. Our data suggest that CFTR-regulated
release contributes to ATP release from contracting muscle in vivo, and that cAMP and PKA are involved in the activation of
CFTR during muscle contractions or acidosis; NHE and NCX may be involved in the signal transduction pathway.
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Introduction
Adenosine was first proposed as a mediator of exercise
hyperaemia more than 50 years ago [1]. Interstitial adenosine is
increased during contractions of both red and white muscles [2–4],
which is estimated to account for about 40% of the vasodilation
[5–8]. Interstitial adenosine is formed extracellularly [9,10]: an
increase in the interstitial adenine nucleotides is the main driving
force for the increased adenosine formation during muscle
contractions [9]. Several authors have documented the increase
in interstitial ATP during muscle contractions [2,11,12], but the
mechanism by which ATP is released from contracting skeletal
muscle cells is unknown.
ATP itself is also considered to be an important extracellular
signalling molecule [13]: as well as giving rise to vasodilator
quantities of adenosine, ATP can induce vasodilation directly
through its action on endothelial P2Y receptors and by inhibition
of sympathetic vasoconstriction [14,15], and it can activate the
muscle pressor reflex through its action on P2X receptors [16].
We previously reported that lactic acid stimulated ATP release
from skeletal muscle through a mechanism that involved the cystic
fibrosis transmembrane conductance regulator (CFTR) [17], and
that muscle pH was negatively correlated with the extracellular
adenosine or ATP concentrations [17–19]. We proposed that the
decrease in pH during muscle contractions stimulated ATP release
from muscle through a CFTR-dependent mechanism, with that
ATP then being converted to adenosine in the interstitial space to
bring about the muscle vasodilation [17].
CFTR is a member of the ATP-binding cassette (ABC)
superfamily of proteins as well as a chloride channel (for recent
review see [20]). CFTR is unique among the ABC transporters
because it exhibits ligand gating, conferred by the presence of a
central ,200-residue regulatory (R) domain containing multiple
serines that can be phosphorylated by cAMP-dependent protein
kinase A (PKA), which facilitates its ATP binding; ATP hydrolysis
then triggers the opening and closing of the Cl2 channel [20]. The
regulation of skeletal muscle CFTR activity has not been
investigated previously.
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Many studies have reported the involvement of ABC proteins in
ATP release [21–23]: CFTR-regulated ATP release has been
observed in a variety of native cell types, including erythrocytes
and epithelial cells [24,25], whilst transfection of carcinoma cells
with CFTR or reconstitution of CFTR into lipid bilayers is
associated with the appearance cAMP-dependent ATP release
[26–28]. The mechanism by which CFTR facilitates the ATP
release from muscle remains controversial: some authors have
proposed that ATP leaves the cell through CFTR itself, whilst
others propose that CFTR regulates the activity of a separate ATP
channel protein [23,29,30].
Here, we investigate the signal transduction mechanism linking
the decrease in pH to CFTR activation, and assess whether CFTR
is involved in ATP release from muscle during contractions in-
vivo. We hypothesised that increased activity of the Na+/H+
exchanger (NHE) at low pH increased intracellular sodium, which
in turn led to increased activity of the Na+/Ca2+ exchanger
(NCX), producing an area of elevated intracellular calcium close
to the cell membrane. According to our model, this calcium could
then activate adenyl cyclase (AC), increasing cAMP, and activate
CFTR through the PKA pathway. This model has been tested
using inhibitors of the proposed signal transduction pathway, and
our findings are consistent with the suggested model.
The involvement of CFTR in ATP release from contracting
muscle was investigated using microdialysis to sample the
interstitial fluid of blood-perfused gastrocnemius muscles of
anaesthetised rats at rest and during muscle contractions: the
increase in interstitial ATP during muscle contractions was
compared in the absence or presence of inhibitors of CFTR itself,
or of key elements in its proposed activation pathway. The findings
are consistent with the proposal that CFTR regulates ATP release
from muscle during contractions.
Materials and Methods
Materials
Chemicals were purchased from Sigma, USA. Stock standard
solutions of ATP, ADP, AMP and adenosine were dissolved in
ultrapure water. Stock solution of forskolin was prepared in
phosphate-buffered saline (PBS). Stock solutions of the other
pharmacological agents (CFTRinh-172, SN6, KB-R7943, amilo-
ride and KT5720) were prepared in DMSO. The final DMSO
concentration did not exceed 1 ml per ml of the perfusion buffer or
bathing medium.
Culture of rat L6 skeletal myoblasts
L6 cells obtained from ATCC (Manassas, VA, USA) were
cultured and maintained in a complete Dulbecco’s Modified Eagle
Medium (DMEM) containing 10% heat-inactivated fetal bovine
serum (FBS), and 1% penicillin/streptomycin (all from Gibco) at
37uC in a humidified 5% CO2 in air atmosphere. Prior to
beginning the experimental procedures, the myoblasts were seeded
into 6-well plates in 1 ml of culture medium containing serum and
antibiotics at a density of 36105 cells per well, and a further 2 ml
of complete growth medium was added. Cells were incubated at
37uC in a humidified 5% CO2 in air atmosphere for 24 hours
prior to protocols leading to the analysis of intracellular
metabolites, or for 48 hours (which allowed them to grow to 80–
90% confluence) prior to measurements of extracellular ATP; the
cells were then washed with PBS, 1 ml of fresh medium without
serum was added to each well, and the experimental treatment
was begun.
Ethics statement
All animal protocols were approved by the University of Hong
Kong Committee on the Use of Live Animals in Teaching and
Research, and all experimental procedures involving animals were
carried out in strict accordance with the animal use guidelines of
the above committee. Experiments were performed under full
anaesthesia, and every effort was made to minimise animal
suffering.
Animal models
Male Sprague-Dawley rats (300 to 450 g) were anaesthetised
with pentobarbital sodium (60–70 mg/kg i.p., Sagatal, RMB,
Animal Health Ltd, Dagenham, UK). A Y-shaped cannula was
placed in the trachea to maintain the airways patent, and animals
were allowed to breathe spontaneously. An external jugular vein
was cannulated for the administration of supplementary doses of
pentobarbital sodium (12 mg/kg whenever toe pinch elicited a
withdrawal reflex) and other drugs. Body temperature was
maintained between 37.5 and 38.5uC by a heating pad and an
external heat lamp.
Constant-flow buffer-perfused hindlimb model. The
surgical preparation was carried out as previously described
[17]. The hindquarters were perfused at 1.5 ml/min via the
abdominal aorta with modified Krebs Henseleit buffer (pH 7.4)
equilibrated against 95% O2/5% CO2. Venous drainage occurred
through a cannula in the inferior vena cava: samples of venous
effluent were collected at intervals for venous pH measurement.
Skin was removed from a hindlimb to expose the calf muscles, and
a microdialysis probe (LM10, Bioanalytical Systems, West
Lafayette Inc, USA) was inserted longitudinally into the soleus
muscle. The exposed muscle was wrapped in the plastic film to
avoid dehydration.
The microdialysis probe was perfused at 2 ml/min with a fluid
of similar composition to the interstitial fluid. Both the hindlimb
muscle and the microdialysis probe was perfused for 90 minutes
before the experimental procedures and sample collection were
begun. The dialysate was collected every 10 minutes in an ice-
cooled vial for HPLC analysis of ATP.
Free-flow blood-perfused hindlimb model. The blood
vessels were left intact, and natural blood perfusion was permitted.
The skin was opened down the posterior aspect of one hindlimb,
and an LM10 microdialysis probe was inserted longitudinally into
the gastrocnemius muscle. The proximal part of the hindlimb was
immobilised using two pins, and the foot was fixed securely to an
upright post. The distal tendon of the gastrocnemius muscle was
tied, cut, and attached to a force transducer (model 50-7915,
Harvard, Edenbridge, UK) for recording of the isometric
contractile force: signals were amplified using a Harvard
transducer amplifier and written onto a Lectromed MX216
recorder (Lectromed, Jersey, UK). An electrode was placed on the
sciatic nerve and connected to the stimulator (model S48, Grass
Instruments, West Warwick, USA). After the surgical preparation
was completed, the skin was sutured back into position to prevent
dehydration.
The microdialysis probe was perfused at 4 ml/min with a fluid
of similar composition to the interstitial fluid. The microdialysis
probe was perfused for 90 minutes before the experimental
procedures and sample collection were begun. The dialysate was
collected every 10 minutes in an ice-cooled vial for analysis of
ATP using a bioluminescent assay.
Microdialysis probe recovery was determined in control
experiments from the regression line of dialysate concentration
versus probe concentration as previously described [11]. ATP
recovery was not altered by the blood flow changes associated with
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muscle contraction: recovery was 57.7% under resting conditions
and 57.1% during contractions. Concentrations shown in this
paper have not been corrected for probe recovery.
Analytical procedures
ATP analysis using HPLC. Dialysis samples from the buffer-
perfused muscle (15–30 ml) were mixed with 105–90 ml ultrapure
water. ATP in the samples was analyzed by ion-pair reverse-phase
HPLC as previously described [11]. The ATP peak was identified
by its retention time and by comparison of its absorption spectrum
to that of the standard. ATP concentrations were quantified using
the area under the peak, and corrected for the dilution factor.
ATP analysis using a bioluminescence assay. The ATP
content of the undiluted samples was determined with the
luciferin-luciferase technique using an ATP bioluminescent assay
kit (Sigma) in a microplate reader (Infinite M200, Techan,
Austria). Samples of the bathing medium from the cultured cells
(100 ml) or of the dialysate from the blood-perfused muscle (30 ml)
were pipetted into a 96-well microplate. ATP assay solution
(100 ml) was added to each well and the luminescent signal was
measured within 1 minute. Sample readings were compared to the
standard curve for 8610211–561028 M ATP. The standard curve
was not significantly altered by any of the inhibitors used in the
study. Intracellular ATP was similarly determined using the Sigma
Bioluminescent Somatic Cell Assay kit, immediately following the
addition of 0.05 ml cell sample to 0.1 ml Somatic Cell ATP
Releasing Reagent plus 0.05 ml ultrapure water and mixing [31].
The number of viable cells was determined by Trypan blue
exclusion, to permit the determination of per cell ATP content.
Western blot. The incubation medium was removed and the
L6 cells were washed twice with PBS then 1 ml lysis buffer
(150 mM NaCl; 50 mM Tris-HCl; 16 mM NP-40 detergent;
6 mM C24H39NaO4; 3.5 mM SDS; 1 mM Na3VO4; 1 mM NaF;
1 mM EDTA; 1 mM phenylmethylsulfonyl fluoride (PMSF);
2.3 mM leupeptin; 1.5 mM pepstatin A; 150 nM aprotinin,
pH 7.4) was added. The extracted proteins were transferred to a
new tube, put on ice for 30 min, then centrifuged at 12,000 rpm
for 20 min at 4uC. The protein concentration of the supernatant
was assayed using the Bradford assay (Bio-Rad). Equal amounts of
protein samples were electrophoresed on 4% stacking gel and 10%
separating gel, then transferred to polyvinylidene fluoride (PVDF)
membrane (Millipore, Bedford, MA) for blotting by standard
protocols using rabbit anti-human polyclonal antibody to residues
55–63 of CFTR (Cell Signaling Technology, Inc., Danvers, MA,
USA). The PVDF membrane with protein was then detected using
chemiluminescence technology (ECL Plus Western Blotting
Reagents, GE Healthcare).
RT-PCR. The incubation medium was removed and the L6
cells were washed twice with PBS. Total RNA was extracted using
an RNeasy Total RNA Extraction Kit (Qiagen GmbH, Hilden,
Germany). cDNA was synthesised from 1 mg of total RNA using
an oligo (dT)18 primer and M-MuLV Reverse Transcriptase
(Fermentas, Canada). cDNA was then amplified using TaqHS
DNA polymerase (Takara Bio Inc., Japan); the specific primers
and the PCR conditions are listed in Table 1 for CFTR and in
Table 2 for AC. After 38 cycles of PCR amplification, the reaction
products were separated on a 2% agarose gel and stained with
ethidium bromide. The band density was assessed and normalised
to that of b-actin (for CFTR) or GADPH (for AC) using Image J
software (version 1.43; NIH).
CFTR phosphorylation assay. CFTR phosphorylation was
measured as described by Chang et al [32]. Cells were washed
twice with phosphate-free MEM containing 8% FBS and 50 mM
Na3VO4 and labelled by incubation in 1 ml of the same medium
containing 100 mCi [c-32P]-ATP (Perkin-Elmer) for 4 hours.
Either forskolin (10 mM) alone or forskolin (10 mM) with
dibutyryl-cAMP (200 mM) and IBMX (1 mM) or DMSO vehicle
was added to the medium for the last 15 mins of the incubation.
Cells were washed twice with PBS, lysed with 1 ml lysis buffer, and
CFTR was immunoprecipitated using the M3A7 monoclonal
antibody (R & D Systems). Protein G dynabeads (Immunoprecip-
itation kit, Invitrogen) were incubated with the antibody at 4uC for
1 hour with rotation, then the cell lysate was added and incubation
was continued for a further 1 hour, before the magnetic beads
were separated using a magnetic particle concentrator (MPC-S,
Dynal A.S., Oslo, Norway) and washed. The antibody-protein
complex was solubilised in 30 ml buffer by heating at 95uC for
8 min prior to SDS-polyacrylamide gel electrophoresis. The gel
was then dried and exposed to x-ray film for 16 hours at 280uC,
after which, the film was analysed by densitometry.
Phosphor-cAMP response element-binding protein
(pCREB) assay. The incubation medium was removed and
the cells were washed twice with PBS then lysed. Western blotting
was performed as described above. Levels of phospho-CREB
(Ser133) and total CREB protein were determined using rabbit
anti-phospho-CREB and rabbit anti-CREB antibodies (Cell
Signaling Technology, USA) followed by HRP-conjugated goat
anti-rabbit IgG (Sigma).
Enzyme immunoassay (EIA) for cytoplasmic cAMP
measurement. The incubation medium was removed and the
L6 cells were washed twice with PBS then lysed. The cAMP
concentration in the cell lysate was determined using the non-
radioactive cAMP-enzyme immunoassay (EIA) kit from Arbor
Assays (Ann Arbor, Michigan, USA) according to the manufac-
turers instructions. All the experiments were carried out with the
acetylated protocol to achieve the maximal sensitivity. The yellow-
coloured product formed with the EIA is inversely proportional to
the amount of cAMP present in the sample, and was detected at
450 nm using a microplate reader (SynergyTM 4, BioTek
Instruments Inc., USA).
Protein kinase A (PKA) phosphorylation assay. The
incubation medium was removed and the L6 cells were washed
twice with PBS then lysed. Lysates were centrifuged at 14,000 g
for 5 mins at 4uC. The activity of cAMP-dependent PKA in the
supernatant was determined using the phosphorylation assay in
the PepTag nonradioactive PKA assay kit (Promega, WI, USA),
according to the manufacturer’s instructions. Samples were loaded
onto 0.8% agarose gels and electrophoresed at 110 V for 20 min.
Experimental procedures
Involvement of CFTR in lactic-acid-induced ATP release
from buffer-perfused rat soleus muscle in-vivo. After all
surgical procedures had been completed, the muscles were
perfused with pH 7.4 buffer for a stabilisation period of at least
90 mins before the sample collection was begun. Two control
10 min samples of microdialysate were first collected. The muscle
was then perfused for 20 mins at a time with buffer containing
increasing doses (2.5–10 mM) of lactic acid, and two micro-
dialysate samples were collected at each dose. Perfusion with
pH 7.4 buffer was then restored for the collection of the two
recovery samples. Infusion of one of the blocker substances was
begun, and the entire protocol was repeated in the presence of the
blocker. The blockers tested were a-cyano-4-hydroxycinnamic
acid (2 mM), an inhibitor of the monocarboxylate transporter,
CFTRinh-172 (20 mM), a specific inhibitor of CFTR, and
glibenclamide (200 mM), a non-specific open-pore blocker for
CFTR. In a separate series of experiments, the effects of 10 mM
lactic acid and 10 mM sodium lactate on interstitial ATP were
cAMP/PKA Regulates CFTR in ATP Release from Muscle
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compared: the muscle was perfused for 20 mins each time with
pH 7.4 buffer, 10 mM lactic acid in buffer, pH 7.4 buffer
(recovery 1), 10 mM sodium lactate in buffer, and pH 7.4 buffer
(recovery 2). Two 10 min microdialysis samples were collected
during each treatment. The ATP content of microdialysis samples
was analysed by HPLC.
Involvement of CFTR in lactic-acid-induced ATP release
from cultured L6 myocytes. Cells were seeded into 6-well
plates and pre-incubated for 48 hrs. Then the medium was
replaced with a serum-free medium. Experimental treatments
(lactic acid and/or inhibitors) were added as appropriate, and the
plates were returned to the incubator for the duration of the
experimental treatment.
In the first series of experiments, the time course of the
appearance of ATP in the extracellular medium was examined:
10 mM lactic acid was added to half of the wells on each plate,
and the plates were incubated for times of 30 min, 1 hr or 3 hrs
before the bathing medium was collected for ATP analysis.
In the second series of experiments, the effect of CFTR
inhibitors on the lactic-acid induced increase in extracellular ATP
was examined: 10 mM lactic acid was again added to half of the
wells on each plate: some plates were left without inhibitors, and
either CFTRinh-172 (20 mM) or glibenclamide (200 mM) was
added to the remaining plates; all plates were incubated for 3 hrs,
then the bathing medium was collected for ATP analysis.
In the third series of experiments, the effect of lactic acid on the
intracellular ATP was determined: various doses of lactic acid (0–
10 mM) were added to the wells, and the plates were incubated for
30 mins. Then the cells were washed, and the intracellular ATP
and numbers of viable cells were determined.
Effect of lactic acid on extracellular ATP breakdown
rate. Cells were seeded into 6-well plates and pre-incubated for
48 hrs. Then the medium was replaced with a serum-free medium
containing CFTRinh-172 (20 mM), ATP (1 mM) and either 0 or
10 mM lactic acid. Samples of the extracellular medium were
removed after 1, 2 and 10 mins of incubation for analysis of ATP,
ADP, AMP and adenosine by HPLC.
The role of cAMP-dependent PKA in the activation of
CFTR in buffer-perfused rat soleus muscle in vivo and
cultured L6 myocytes in vitro. The effect of forskolin on the
interstitial ATP of buffer-perfused soleus muscle in vivo was
determined: the muscle was perfused with pH 7.4 buffer for a
20 min control period, then forskolin (20 mM) was infused for a
further 30 mins, followed by another 10 mins recovery period of
buffer-only perfusion. Microdialysis samples were collected for
10 mins each throughout the experimental period for HPLC
analysis of ATP.
The effect of forskolin on the extracellular ATP of the cultured
myocytes was tested. Cells were seeded into 6-well plates and pre-
incubated for 48 hrs. Then the medium was replaced with a
serum-free medium: forskolin (100 mM) was added to 3 of the wells
Table 1. Specific primers and PCR conditions used for RT-PCR analysis of CFTR mRNA expression.
Gene
GenBank
Accession No. Primer Sequence (59-39)
Annealing
Temperature (6C)
CFTR (236 bp) NC_005103 Sense: GTGGCTCCCATTGTCGTAGT
Antisense: GGCCGGTTTGTTCTTTATCA
64.0
b-actin (240 bp) NM_001101 Sense: CACGATGGAGGGGCCGGACTCATC
Antisense: TAAAGACCTCTATGCCAACACAGT
60.4
doi:10.1371/journal.pone.0050157.t001
Table 2. Specific primers and PCR conditions used for RT-PCR analysis of AC isoform mRNA expression.
AC gene
GenBank Accession
No. Primer Sequence (59-39)
Annealing temperature
(6C)
mAC 1 (521 bp) AF053980 sense: CCACGTCCTACATCCTCGTT
antisense: AAGTGGTAGGGGCACCTTCT
53
rAC 2 (302 bp) M80550 sense: CGTGTCACTCTC
antisense: CCTTGTTCACATCTGACTC
64
rAC 3 (442 bp) M55075 sense: CATCGAGTGTCTACGCTTC
antisense: GGATGACCTGTGTCTCTTCT
64
rAC 4 (455 bp) M80633 sense: GGAAGACGAGAAGGGCACCGAGAG
antisense: GAGCTGGGGGCCTGGTTGTCAC
64
rAC 5 (498 bp) M96159 sense: ACCATTGTGCCCCACTCCCTGTT
antisense: TCGTCGCCCAGGCTGTAGTTGAA
64
rAC 6 (417 bp) LO1115 sense: CAAAGGAAGGGACGCCGAGAGG
antisense: TGGGGACAGATCACGGGACTAGGA
51
mAC 7 (560 bp) U12919 sense: CCAGTTATTTAGAGAGAGACCTG
antisense: CTTGCTCATCAGGGCCATGCTAA
58
mAC 8 (628 bp) L26986 sense: TTCACTTGAGCCTAGCCTCG
antisense: GGATGTAGATGCGGTGGAAC
55
mAC 9 (312 bp) U30602 sense: AGCTTATCCTCACCTTCTTCTTCCTC
antisense: AGGACACGGTAGCACTCCTTGCC
54
doi:10.1371/journal.pone.0050157.t002
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on some plates, and lactic acid (10 mM) was added to 3 of the
wells on the remaining plates. All plates were incubated for 3 hrs,
then the extracellular medium was withdrawn for ATP analysis.
The effect of IBMX on the extracellular ATP of the myocytes,
in the absence or presence of lactic acid, was also tested. Cells were
prepared as above: 10 mM lactic acid was added to half of the
wells on each plate; IBMX (1 mM) was added to all 6 wells on half
of the plates, and plates were incubated for 3 hours before
collection of the bathing medium for ATP analysis.
The influence of lactic acid and sodium lactate on the
intracellular cAMP of the cultured myocytes was examined: cells
were seeded into 6-well plates and pre-incubated for 24 hrs before
the medium was replaced with serum-free medium. One of the
following was then added to each well: no addition, lactic acid (2.5,
5 or 10 mM) sodium lactate (2.5, 5 or 10 mM). All plates were
incubated for 30 mins, then the cells were washed and lysed for
measurement of cAMP in the lysate. The maximal cAMP response
was determined in a separate group of cells by the addition of a
range of forskolin concentrations to different wells, followed by
incubation for 30 mins, and cAMP determination as above.
The influence of lactic acid on the induction of pCREB was
examined in the myocytes. Cells were seeded into 6-well plates and
pre-incubated for 24 hrs before the medium was replaced with
serum-free medium. Lactic acid (2.5, 5 or 10 mM) was added to
some of the wells, and others were left untreated as controls. All
plates were incubated for 30 mins, then the cells were washed and
lysed for the determination of pCREB and total CREB in the
lysates.
The effect of the PKA inhibitor, KT5720, on the extracellular
ATP of the cultured myocytes and on the interstitial ATP of the
buffer-perfused soleus muscle, in the absence or presence of lactic
acid, was tested. Myocytes were seeded into 6-well plates and pre-
incubated for 48 hrs. Then the medium was replaced with serum
free medium: 10 mM lactic acid was added to half of the wells on
each plate; KT5720 (20 mM) was added to all 6 wells on half of the
plates, and all plates were incubated for 3 hours before collection
of the bathing medium for ATP analysis. The soleus muscle was
perfused with pH 7.4 buffer throughout the 90 min equilibration
period and for a further 20 min control period. Then lactic acid
(5 mM) was infused for 20 mins, followed by a 20 mins recovery
period with pH 7.4 buffer perfusion. Infusion of KT5720 (10 mM)
was begun, and the lactic acid treatment protocol was repeated in
the presence of KT5720. Microdialysis samples were collected for
10 mins each throughout the experimental period for HPLC
analysis of ATP.
The effect of lactic acid on PKA activity was determined in the
supernatant from the cell lysate: cells were incubated with 0, 2.5, 5
or 10 mM lactic acid for 20 mins, then lysed, and PKA activity
was assayed as described above.
The influence of lactic acid on the expression of
CFTR. L6 myocytes were seeded into 6-well plates and pre-
incubated for 24 hrs before the medium was replaced with serum-
free medium. In the first series of experiments, lactic acid (2.5, 5 or
10 mM) was added to some of the wells, and others were left
untreated as controls. After 30 mins incubation, the cells were
washed twice, and the CFTR mRNA expression was determined
using RT-PCR. In the second series of experiments, 10 mM lactic
acid was added to half of the wells, and the plates were incubated
for 3 hrs before the cells were washed and lysed for determination
of CFTR protein using Western blot.
Involvement of NHE and NCX in the acidosis-induced
release of ATP from L6 myocytes. Cells were seeded into 6-
well plates and pre-incubated 24 hrs if destined for intracellular
cAMP measurements, or 48 hrs if destined for extracellular ATP
measurements. Then the medium was replaced with serum free
medium: lactic acid (10 mM) was added to 3 of the wells on each
plate. The NHE inhibitor, amiloride (100 mM), was added to all
wells on some plates, and one of the NCX inhibitors, SN-6
(20 mM) or KB-R7943 (10 mM), was added to all wells of other
plates. All plates for cAMP measurements were incubated for
30 mins, then the cells were washed and lysed for measurement of
cAMP in the lysate. Plates for extracellular ATP measurement
were incubated for either 30 mins (amiloride-treated plates and
their controls) or 3 hrs (SN-6- or KB-R7943-treated plates and
their controls): then the bathing medium was removed for ATP
analysis.
Involvement of CFTR in the release of ATP from the
contracting skeletal muscle in vivo. Experiments were
performed in the free-flow blood-perfused gastrocnemius muscles
of anaesthetised rats. Following the 90 min equilibration period,
collection of interstitial microdialysis samples was begun. Muscles
were given a 20 min rest period, then a 20 min period of 1 Hz
contractions, followed by a 20 min recovery period. One of the
inhibitors was given as a bolus injection, and the whole procedure
was repeated. Inhibitor doses were selected to give plasma
concentrations of CFTRinh-172= 20 mM or KT5720= 10 mM or
amiloride = 100 mM or SN-6= 20 mM. A control series of
experiments was performed in which the muscle was subjected
to two bouts of contractions without any inhibitor being given, in
order to ensure that the release of ATP into the interstitial space
would be reproducible in repeated contractions. The ATP
concentration in the microdialysate samples was analysed using
the bioluminescence assay.
Statistical analysis
All data are expressed as means 6 SEM. Results from the in
vivo experiments are expressed as a percentage of their own
control for statistical analyses, to minimise the influence of inter-
animal variations, and n represents the number of animals used.
One-way repeated measures ANOVA followed by the Bonferroni
post hoc t-test was performed for comparing multiple treatments
within the same group of animals. In the in vitro experiments, n
represents the number of tests: Student’s t-test was used to
compare single groups to their control and one-way ANOVA
followed by the Bonferroni post hoc t-test was used for multiple
comparisons. In all cases significance was established at P,0.05.
Results
Involvement of CFTR in lactic-acid-induced ATP release
from skeletal muscle
Addition of 10 mM lactic acid to the bathing medium of L6
myocytes reduced the pH from 7.4160.01 to 6.3460.06 (n= 11)
within the first min; however, the hydrogen ions were rapidly
taken up and/or buffered: after 30 mins of incubation, the
medium pH had increased to a value not significantly different
from the wells without lactic acid, and it remained stable at
7.4560.02 (n= 10) from 1 to 3 hours of incubation. The
extracellular ATP concentration was significantly increased within
the first 30 mins of lactic acid treatment; the ATP content of the
bathing medium remained elevated for 3 hours (Fig. 1A), but had
returned to control after 6 hours. Incubation of the myocytes for
30 mins in a medium containing lactic acid at either 5 or 10 mM
significantly decreased the mean cell content of ATP (Fig. 1C).
Either the specific inhibitor of CFTR, CFTRinh-172, or the CFTR
open-pore blocker, glibenclamide, abolished the increase in
extracellular ATP induced by 3 hours incubation of the myocytes
in a medium containing lactic acid (10 mM) (Fig. 1B).
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The mean interstitial ATP concentration of the rat soleus
muscle during perfusion with pH 7.4 buffer was 4164 nM
(n= 36), and the venous pH was 7.2260.04 (n= 13). Infusion of
lactic acid produced dose-dependent increases in the interstitial
ATP (Fig. 2A), which were abolished in the presence of the
monocarboxylate transporter inhibitor, a-cyano-4-hydroxycin-
namic acid (Fig. 2B), the specific inhibitor of CFTR, CFTRinh-
172 (Fig. 2C), or the CFTR open-pore blocker, glibenclamide
(Fig. 2D). None of the inhibitors significantly altered the interstitial
ATP during perfusion with pH 7.4 buffer. Sodium lactate, which
failed to significantly reduce the venous pH, also failed to
significantly increase the interstitial ATP (6164 nM in control
and 7264 nM with sodium lactate). The interstitial ATP
concentration was well-correlated with the decrease in venous
pH (r = 0.91).
Effect of lactic acid on extracellular ATP breakdown rate
There was no significant difference in the rate of extracellular
breakdown of ATP between the cells incubated at pH 7.4 or those
with 10 mM lactic acid added: over the 10 min incubation period,
extracellular ATP decreased to 80.464.4% of its starting
concentration at pH 7.4, and to 73.664.9% in the presence of
lactic acid. At the end of the incubation period, the concentrations
of both ADP, the product of ecto-ATPase, and adenosine, the
product of 59-nucleotidase, were similar in both groups.
The role of cAMP-dependent PKA in the activation of
CFTR in skeletal muscle
Infusion of forskolin to the buffer-perfused rat soleus muscle in
vivo resulted in a significant elevation of the interstitial ATP
concentration (Fig. 3A). Similarly, addition of forskolin to the
bathing medium of the L6 cultured myocytes produced an
increase in extracellular ATP of similar magnitude to that
produced by 10 mM lactic acid treatment (Fig. 3B). The
phosphodiesterase inhibitor, IBMX, significantly increased the
rate of appearance of ATP in the bathing medium of the L6
myocytes, both in the absence and in the presence of lactic acid
(Fig. 3B). Treatment of the L6 myocytes with lactic acid produced
dose-dependent increases in the intracellular cAMP concentration,
whereas sodium lactate failed to elevate intracellular cAMP
(Fig. 3C). 10 mM lactic acid raised the intracellular cAMP to
7.161.0 nM, whereas the maximal cAMP response to forskolin
was 9.0 nM (Fig. 3D). Lactic acid produced dose-dependent
increases in the L6 myocyte pCREB content, a surrogate for the
activation of PKA by cAMP, whereas total CREB protein
remained unchanged (Fig. 4A–C). CFTR phosphorylation was
increased by the addition of forskolin alone, and further increased
by the addition of forskolin plus dibutyryl-cAMP and IBMX, but
the forskolin-induced increase in CFTR phosphorylation was
inhibited by KT5720 (Fig. 4D–E). The phosphorylating activity of
PKA in the lysate of L6 myocytes was increased following 30 mins
incubation in the presence of lactic acid. (Fig. 5A): treatment with
5 mM lactic acid increased the PKA activity from 30.664.5 to
37.065.4 pmol/min (n = 8; P,0.02, paired t-test), whereas
western blot of b-actin (the internal standard) confirmed that total
protein loading of the gels remained constant (Fig. 5A). Inhibition
Figure 1. Influence of lactic acid on the extracellular and
intracellular ATP of L6 cultured myocytes. A: time-course for the
appearance of ATP in the bathing medium during exposure to 10 mM
lactic acid. Values are the mean 6 SEM of 14–30 values; *, significantly
different from its own time-control in Student’s t-test. B: appearance of
ATP in the bathing medium following 3 hrs exposure to 10 mM lactic
acid in the absence of inhibitors or in the presence of CFTRinh-172
(20 mM) or glibenclamide (200 mM). Values are the mean6 SEM of 9–12
tests. *, significant difference between the presence and absence of
lactic acid in Student’s t-test; #, significant difference between the
presence or absence of the inhibitor in 1-way ANOVA followed by the
Bonferroni post-hoc t-test. C: effect of incubation for 30 mins in
different concentrations of lactic acid on the intracellular ATP. Values
are the mean6 SEM of 6–12 values; *, significantly different from 0 mM
lactic acid in 1-way ANOVA followed by the Bonferroni post-hoc test.
doi:10.1371/journal.pone.0050157.g001
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of PKA using KT5720 abolished the lactic-acid-induced increases
in extracellular ATP of cultured L6 myocytes (Fig. 5B) and
interstitial ATP of buffer-perfused rat soleus muscle (Fig. 5C–D).
The influence of lactic acid on the expression of CFTR
Incubation with lactic acid produced dose-dependent increases
in the CFTR mRNA expression, whereas the mRNA for b-actin,
the internal standard, remained unchanged (Fig. 6A & 6C).
Expression of CFTR protein was also increased by lactic acid
treatment: density of the mature fully-glycosylated CFTR band at
168 kDa was significantly increased, whereas, the density of the
immature band at 150 kDa was not significantly affected (Fig. 6B
& 6D).
Adenyl Cyclase isoforms expressed by L6 myocytes
Expression of mRNA for the AC isoforms 3, 6, 7, 8 and 9 was
detected using RT-PCR (Fig. 6E–F). ACs 1, 2 and 5 were not
detected.
Involvement of NHE and NCX in the acidosis-induced
release of ATP from L6 myocytes
Treatment with the NHE blocker, amiloride, abolished the
lactic-acid-induced increases in intracellular cAMP (Fig. 7A) and
extracellular ATP (Fig. 7B) of cultured L6 myocytes. Similarly, the
NCX blocker, SN6, abolished the lactic-acid-induced increases in
both intracellular cAMP (Fig. 8A) and extracellular ATP (Fig. 8B)
of cultured L6 myocytes. The NCX blocker KB-R7943 signifi-
cantly reduced (but did not fully abolish) the lactic-acid-induced
increase in intracellular cAMP (Fig. 8A) but it did abolish the
increase in extracellular ATP (Fig. 8B) of the myocytes.
Involvement of CFTR in the release of ATP from the
contracting skeletal muscle in vivo
Under resting conditions, the interstitial ATP of the blood-
perfused rat gastrocnemius muscle was 3.660.4 nM (n= 37).
Muscle contractions at 1 Hz significantly increased the interstitial
ATP to 80.8611.9 nM in the first 10 mins (P,0.001, 1-way
repeated measures ANOVA and Bonferroni post-hoc t-test).
Figure 2. Influence of lactic acid on interstitial ATP of buffer-perfused soleus muscle of anaesthetised rats. Effect of lactic acid on
interstitial ATP in the absence of inhibitors (A) or in the presence of a-cyano-4-hydroxycinnamic acid (2 mM; B), CFTRinh-172 (20 mM; C) or
glibenclamide (200 mM; D). Values are the mean6 SEM of 14–17 values in A, 6 values in B, 7 values in C or 6 values in D. *, significantly different from
the pre-control in 1-way repeated measures ANOVA followed by the Bonferroni post-hoc t-test.
doi:10.1371/journal.pone.0050157.g002
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Between 10 and 20 mins of contractions, the interstitial ATP was
significantly lower than that during the first 10 mins: overall, in the
whole group of 37 animals, interstitial ATP remained significantly
above control between 10 and 20 mins of contractions, at
33.866.0 nM (P,0.001); however, in three of the five subgroups
of animals, interstitial ATP was not significantly greater than
control in the second contraction sample (Figs. 9A, 9B & 9E),
although, in two of these subgroups, it was significantly higher
than control in a t-test.
In the control experiment, the increase in interstitial ATP
during the second period of contractions was very similar to that
during the first contraction (Fig. 9A), indicating that the responses
were reproducible in repeated bouts of contractions. However, the
contraction-induced increase in interstitial ATP was abolished by
the infusion of the specific CFTR inhibitor, CFTRinh-172 (Fig. 9B),
the PKA inhibitor, KT5720 (Fig. 9C), the NHE inhibitor,
amiloride (Fig. 9D) or the NCX inhibitor (Fig. 9E). The force of
contraction did not differ significantly between the first and second
contraction, either in the absence of drugs (Fig. 10A) or in the
presence of any of the inhibitors (Fig. 10B to 10E).
Discussion
We have proposed a model for the CFTR-regulated release of
ATP from skeletal muscle, in which a decrease in intracellular pH
stimulates hydrogen ion extrusion from the cell by the NHE,
resulting in sodium entry to the muscle, which, in turn, leads to
sodium extrusion by the NCX, and allows calcium entry. We
hypothesised that the calcium then activates adenyl cyclase,
producing a localised increase in cAMP, which activates PKA.
PKA phosphorylates the regulatory domain of CFTR, leading to
its activation, which results in ATP release from the cell. In this
Figure 3. Role of intracellular cAMP in stimulating the increase in extracellular ATP at low pH. A: influence of forskolin (20 mM) on the
interstitial ATP of buffer-perfused rat soleus muscle. Values are the mean6 SEM of 5 observations. *, significantly greater than the precontrol in 1-way
repeated measures ANOVA followed by the Bonferroni post-hoc t-test. B: comparison of the effect of forskolin (20 mM) or lactic acid (10 mM) in the
absence or presence of IBMX on the appearance of ATP in the bathing medium of L6 cultured myocytes. Values are the mean6 SEM of 12–27 tests. *,
significantly different from its own control group in Student’s t-test; #, significant difference between the absence or presence of IBMX (Student’s t-
test). C: influence of lactic acid or sodium lactate on the intracellular cAMP of L6 cultured myocytes. Values are the mean 6 SEM of 15 values for
control and of 6–9 values for treatments. *, significantly different from control in 1-way ANOVA followed by the Bonferroni post-hoc t-test. D:
determination of the maximal cAMP response to forskolin in the L6 myocytes: the line shows the 5-parameter sigmoid curve fit (r = 1.0) which
predicts a maximal cAMP response of 9.0 nM.
doi:10.1371/journal.pone.0050157.g003
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study, we have found strong evidence that cAMP/PKA activation
of CFTR is involved in ATP release from muscle; our preliminary
experiments using inhibitors of the NHE and NCX are also
consistent with the proposed model.
Lactic acid treatment stimulated ATP release from skeletal
muscle in vivo and in vitro. The ATP release was stimulated by the
lowering of pH rather than the lactate anion, since sodium lactate
infusion (which did not significantly reduce pH) failed to stimulate
ATP release, the increase in interstitial ATP was negatively
correlated with the extracellular pH, and inhibition of the lactic
acid uptake abolished the acidosis-induced ATP release. Both
specific and non-specific inhibitors of CFTR abolished the lactic-
acid-induced ATP release in vivo and in vitro, strongly suggesting
that CFTR is involved in the ATP release.
In the present study, lactic acid induced ATP release from the
soleus muscle in similar quantities and with a similar time-course
to the release from EDL muscle in our previous study [17],
suggesting that the release mechanism is similar in both red and
white muscle. The similarity between the responses to lactic acid of
the perfused muscle in-vivo and the L6 cultured cells in vitro, with
or without the blocking drugs, further suggests that the ATP is
released from skeletal muscle cells themselves, and that the entire
signal transduction mechanism is confined to the skeletal muscle
cells alone.
The cAMP/PKA pathway was shown to be involved in the
signal transduction pathway for CFTR-regulated ATP release
from skeletal muscle: forskolin treatment increased CFTR
phosphorylation and stimulated ATP release from muscle both
in vivo and in vitro, whilst treatment of the myocytes with lactic
acid elevated both the intracellular cAMP and its surrogate,
pCREB, and treatment with the phosphodiesterase inhibitor,
IBMX [33], enhanced the ATP release from myocytes in the
absence or presence of lactic acid. An earlier study on rat soleus
muscle also reported that a glycolysis-induced increase in the
endogenous production of lactate resulted in the elevation of
cAMP [34]; cardiac myocytes from neonatal rats and mice have
previously been shown to exhibit cAMP-stimulated CFTR-
dependent ATP release [35,36]. Pretreatment of myocytes with
lactic acid increased the PKA activity, whereas inhibition of PKA
with KT5720 abolished the lactic-acid-induced release of ATP
from muscle both in vivo and in vitro, and inhibited the CFTR
phosphorylation induced by forskolin. It has previously been
shown that the open-state probability of CFTR in excised
membrane patches was increased at low pH, due to an increase
in the MgATP affinity of the NBDs [37]: this mechanism may also
contribute to the activation of CFTR at low pH in vivo, but
cAMP/PKA activation appears to be an essential step in the intact
cell, since the acidosis-induced ATP release was completely
abolished in the presence of PKA inhibition.
AC exists in 9 transmembrane and at least one soluble isoform
[38], which have different regulatory properties. Transmembrane
ACs 1, 3 and 8 are stimulated by calcium, through calcium/
Figure 4. Influence of lactic acid on the induction of pCREB and
influence of forskolin on CFTR phosphorylation in L6 cultured
myocytes. A: sample gel showing the bands for pCREB, CREB and b-
actin, which served as the internal control. Band density for pCREB (B) or
total CREB (C) was expressed as a ratio to b-actin. Values are the mean
6 SEM of 3 tests. *, significantly different from the value in the absence
of lactic acid in 1-way ANOVA followed by the Bonferroni post-hoc t-
test. D: sample autoradiograph showing the change in CFTR
phosphorylation in response to forskolin (20 mM), forskolin with
KT5720, or forskolin plus dibutyryl-cAMP (200 mM) and IBMX (1 mM).
E: densitometry analysis of CFTR phosphorylation under the same
conditions.
doi:10.1371/journal.pone.0050157.g004
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calmodulin binding [39]; ACs 5 and 6 are inhibited by calcium,
and ACs 2, 4 and 7 are not directly affected by calcium [40],
although, 2 and 7 are stimulated by protein kinase C (PKC), and
may thus be indirectly activated by calcium [41]. AC9 is indirectly
inhibited by calcium via calcineurin [40], whereas soluble AC is
directly activated by calcium, which increases its affinity for ATP
[42]. The calcium/calmodulin-stimulated transmembrane ACs
are closely associated with sites of calcium entry to the cell [39],
and the calcium signal is thought be localised to a microdomain
close to the cell membrane [40].
Our proposed model suggests that calcium entry through the
NCX is responsible for activating AC, leading ultimately to CFTR
activation and increased ATP release. This mode of entry would
be likely to localise the increased calcium concentration to a
microdomain near the membrane, which is consistent with our
current understanding of AC regulation; logic also dictates that in
a tissue such as skeletal muscle, which undergoes elevation of the
bulk intracellular calcium concentration during every contraction,
a metabolic signal mediated by raised intracellular calcium would
need to be compartmentalised to confer sensitivity. Clearly the
feasibility of the model is dependent on the expression of a
calcium-activated AC isoform in skeletal muscle. We have found
mRNA expression of two Ca-activated ACs (AC3 and 8) in
muscle, along with two Ca-inhibitable ACs (AC6 and 9), and AC7,
which may be indirectly activated by calcium. Further work is
required to confirm the protein expression of these ACs, and to
determine which of them associate with PKA and/or CFTR.
Incubation of the myocytes with lactic acid increased the CFTR
mRNA and protein expression. Phosphorylated CREB is an
important regulator of the basal transcription of the CFTR gene,
and mediates the effects of PKA on protein synthesis. The cAMP-
PKA-activated CREB is able to bind various nuclear proteins and
thus to react with several nucleic sequences, particularly the cAMP
responsive element (CRE) motif. The CFTR gene contains a CRE
in its promoter, at the position of 248 [43]. On the other hand,
cAMP-stimulated CFTR gene transcription can also be increased
by stimulated expression, which is dependent on nucleotide
sequences such as NFkB, SP1, or AP1, known to correspond to
inflammation-induced transcription factors [44]. In our experi-
ment, the skeletal myocytes were incubated with lactic acid only
for 30 minutes, so the enhancement of CFTR gene expression
may be through the stimulated expression mechanism rather than
the basal expression mechanism. However, the effects of lactic
acidosis on inflammation-induced transcription factors remain
controversial, and the mechanism by which lactic acid induced
enhancement of CFTR gene and protein expression requires
further investigation.
Figure 5. Involvement of PKA in lactic-acid-induced ATP
release from cultured myocytes or perfused muscle. A: PKA
activity was measured in the supernatant from the L6 myocyte lysate
following 30 mins incubation of the cells with the concentrations of
lactic acid shown. The upper sample gel shows the separated bands of
phosphorylated and non-phosphorylated peptide, and the lower gel
shows the internal standard, b-actin, which was measured to confirm
that the loading of the gel was kept constant. B: Appearance of ATP in
the bathing medium of L6 myocytes exposed to 10 mM lactic acid in
the absence or presence of KT5720 for 3 hrs. Values are the mean 6
SEM of 9–13 tests. *, significant difference between the absence or
presence of lactic acid;#, significant difference between the absence or
presence of KT5720 (1-way ANOVA followed by the Bonferroni post-hoc
t-test). C & D: Appearance of ATP in the interstitial space of buffer-
perfused rat soleus muscle during infusion of lactic acid (5 mM) in the
absence (C) or presence (D) of KT5720. Values are the mean 6 SEM of
11 (C) or 6 (D) tests. *, significant difference between the absence or
presence of lactic acid in 1-way repeated measures ANOVA followed by
the Bonferroni post-hoc t-test.
doi:10.1371/journal.pone.0050157.g005
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We found that either amiloride (an NHE inhibitor) or SN6 or
KB-R7943 (NCX inhibitors) abolished the lactic-acid-induced or
contraction-induced ATP release from muscle, suggesting that
these exchange proteins may be involved in the signal transduction
mechanism leading to ATP release.
In skeletal muscle, NHE mediates the majority of the pH
recovery following an acid load [45], by extruding protons from
the cell in a 1-to-1 exchange with extracellular sodium ions, which
elevates the intracellular sodium [45,46]. NHE activity is
stimulated by a decrease in intracellular pH [46]. Thus, the
Figure 6. CFTR and AC isoform expression in L6 myocytes. A: sample gel showing RT-PCR of CFTR and the internal standard, b-actin, from
cells incubated for 30 mins with the concentrations of lactic acid shown. C. CFTR mRNA expression was normalised as the ratio to b-actin. Values are
the mean6 SEM of 4 tests. *, significant difference between the absence or presence of lactic acid in 1-way ANOVA followed by the Bonferroni post-
hoc t-test. B: sample gel showing western blot of CFTR protein from cells incubated for 3 hrs in the absence or presence of 10 mM lactic acid. D: CFTR
protein expression was normalised as the ratio to b-actin; both the mature (168 kDa) and immature (150 kDa) bands were quantitated. Values are the
mean 6 SEM of 8–9 tests. *, significant difference between the absence or presence of lactic acid in 1-way ANOVA followed by the Bonferroni post-
hoc t-test. E: sample gel showing RT-PCR determination of AC isoforms expressed by L6 myocytes. F: AC mRNA expression was normalised as a ratio
to GAPDH. Values are the mean 6 SEM of 3 values.
doi:10.1371/journal.pone.0050157.g006
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decreased intracellular pH resulting from lactic acid infusion in
our study must have elevated the intracellular sodium. During
muscle contractions, it is known that free intracellular sodium is
increased [47], which had been attributed to sodium entry during
the action potential. However, since the intracellular pH is
decreased during muscle contractions [48], sodium entry via the
NHE must also contribute to the increased intracellular sodium
during muscle contraction.
In cardiac muscle, NHE-mediated accumulation of intracellular
sodium drives calcium entry via the NCX [49,50], and this
mechanism is thought to be a major contributor to ischaemic and
reperfusion injury [51]. We now propose that a similar mechanism
operates in skeletal muscle, and that NHE-mediated extrusion of
hydrogen ions during acidosis or muscle contractions also leads to
calcium entry via NCX. The finding that amiloride inhibited the
contraction- or lactic-acid-induced ATP release from muscle is
consistent with the suggestion that NHE-mediated elevation of
intracellular sodium is involved in the signal transduction pathway
for ATP release, but it remains possible that amiloride directly
inhibited the NCX in our study: therefore, further investigation is
required to clarify the role of the NHE.
Both NCX1 and NCX3 are expressed in skeletal muscle [52],
and exercise training increases the NCX level [53]; the entry of
extracellular calcium through the NCX is suggested to play a
protective role in high frequency fatigue of skeletal muscle [54]. It
has been demonstrated that the NCX can function in reverse-
mode in skeletal muscle [55], and that increased cytoplasmic
sodium drives reverse-mode operation of the NCX [56], but the
possible interaction between NHE and NCX function in skeletal
muscle is not well-studied; there is one report that NHE inhibition
significantly reduced intracellular calcium accumulation in a
muscular dystrophy model [57].
Our data suggest that CFTR-regulated release makes a major
contribution to the increased interstitial ATP of contracting
muscle in vivo, that PKA is involved in the activation of CFTR
during the muscle contractions, and that both the NHE and NCX
may be involved in initiating the signal transduction pathway.
None of the inhibitors significantly reduced the contractile force of
the muscle, and therefore, the attenuation of ATP release in their
Figure 7. Influence of amiloride on lactic-acid-induced increas-
es in myocytes intracellular cAMP and extracellular ATP.
Influence of amiloride on the intracellular cAMP (A) and the extracellular
ATP (B) of L6 cultured myocytes incubated for 30 mins in the absence
or presence of lactic acid (10 mM). Values are the mean 6 SEM of 6–9
tests (A) or 12–27 tests (B). *, significant difference between the absence
or presence of lactic acid;#, significant difference between the absence
or presence of amiloride (1-way ANOVA followed by the Bonferroni
post-hoc t-test).
doi:10.1371/journal.pone.0050157.g007
Figure 8. Attenuation of acid-induced increases in intracellular
cAMP and extracellular ATP by SN6 or KB-R7943. A: L6 myocytes
were incubated in the absence or presence of lactic acid (10 mM) for
30 mins, and values are the mean6 SEM of 6–9 tests. B: myocytes were
incubated in the absence or presence of lactic acid (10 mM) for 3 hrs,
and values are the mean6 SEM of 12–27 values. *, significant difference
between the absence or presence of lactic acid;#, significant difference
between the absence or presence of inhibitor (1-way ANOVA followed
by the Bonferroni post-hoc t-test).
doi:10.1371/journal.pone.0050157.g008
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Figure 9. Effect of muscle contractions on interstitial ATP of perfused muscle with or without inhibitors. Blood-perfused rat
gastrocnemius muscle was subjected to repeated muscle contractions at 1 Hz in the absence of inhibitors (A) or in the presence of CFTRinh-172
(20 mM; B), KT5720 (10 mM; C), amiloride (100 mM; D) or SN-6 (20 mM; E). Values are the mean 6 SEM of 6 (A), 11 (B), 7 (C), 8 (D) or 5 (E) tests. *,
significant difference between rest and contractions; #, significant difference between absence and presence of inhibitor (1-way repeated measures
ANOVA followed by the Bonferroni post-hoc t-test).
doi:10.1371/journal.pone.0050157.g009
Figure 10. Comparison between force generated in the first and second contractions of perfused muscle. Blood-perfused rat
gastrocnemius muscle was subjected to repeated muscle contractions at 1 Hz in the absence of inhibitors (A) or in the presence of CFTRinh-172
(20 mM; B), KT5720 (10 mM; C), amiloride (100 mM; D) or SN-6 (20 mM; E). Values are the mean 6 SEM of 5–11 tests. There were no significant
differences between the first and second contractions in the absence or presence of any inhibitors.
doi:10.1371/journal.pone.0050157.g010
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presence could not be explained by any diminution in the work of
the muscle; furthermore, in the absence of inhibitors, the release of
ATP to the interstitial space remained extremely reproducible in
repeated contractions, which rules out any time-dependent decline
in muscle function.
We did not use inhibitors of ATP breakdown or adenosine
uptake in this study: thus the extracellular and interstitial ATP
concentrations represent the resultant of the processes of release,
uptake and breakdown. This has the advantages that it more
closely represents the situation in vivo and avoids any possible side-
effects from inhibitors, but it means that an increased extracellular
concentration is only an indirect measure of increased ATP
release. However, we are confident that an increased extracellular
ATP concentration does reflect an increase in ATP release, firstly
because the increased extracellular ATP was accompanied by a
decrease in intracellular ATP, secondly because both ATP
breakdown and adenosine uptake are concentration-driven
processes, whose rates would increase in proportion to the
extracellular ATP, and thirdly because we have confirmed that
the rate of extracellular ATP breakdown was unchanged at low
pH.
The inter-animal variation in the interstitial ATP level was
unlikely to result from tissue damage during probe insertion, firstly
because the probe was perfused for 1K hours before samples were
collected, during which time the interstitial ATP decreased to a
steady level, and secondly because those animals having lower
interstitial ATP under control conditions, also tended to have
lower levels during acid infusion or muscle contractions. It is more
likely that the variation arose either from a genuine inter-animal
variability in the capacity for ATP release, or else from differences
in the probe recovery between different experiments. In order to
minimise differences in probe recovery, we always used a brand
new probe for each experiment, and the recovery measured in the
in-vivo control experiments appeared to be quite consistent. We
were unable to use an internal standard to measure recovery for
individual samples, as the entire sample collected was required for
the ATP analysis. Therefore, we normalised the in-vivo concen-
trations to a percentage of their own control, which would
effectively correct for any variability in either probe recovery or
capacity for ATP release.
After correction for the probe recovery, the control interstitial
ATP was in the range 20–170 nM in the buffer-perfused muscle,
and 2–20 nM in the blood-perfused muscle, which is in good
agreement with our own previous measurements [11,17], and
values determined by other groups for muscle [2,15,58] and other
tissues [59,60]. Interstitial ATP increased 1000–3000% in the first
10 mins of muscle contractions, which is similar to the increase
during leg extensor exercise in humans [2,15]. It decreased
between 10 and 20 mins of contractions, remaining significantly
above control in only half of the muscles. This could result from
decreased ATP release from the muscle cells or increased removal
of ATP from the interstitial space. The contractile force was well-
maintained throughout the contractions, which rules out contrac-
tion failure as a cause for decreased ATP release. However, in
prolonged sub-maximal contraction of rat muscle, the intracellular
pH is reported to reach its minimum value after 5–10 mins, and to
increase back to a value only slightly lower than rest if the exercise
is continued to the steady state [61–63]: if the decreased
intracellular pH is one of the signal transduction steps leading to
ATP release, then it is possible that the rebound in pH might
account for a reduction in ATP release between 10 and 20 mins of
contractions.
In conclusion, we have shown that CFTR is involved in the
ATP release from skeletal muscle during acidosis, both in vivo and
in vitro, and that CFTR-regulated ATP release makes a major
contribution to the ATP release from contracting skeletal muscle.
CFTR was activated mainly through the cAMP/PKA pathway,
and our data are consistent with a mechanism whereby both the
NHE and the NCX are involved in the signal transduction
mechanism relating the reduction in intracellular pH to the
activation of CFTR.
Author Contributions
Conceived and designed the experiments: HJB JT LL WC. Performed the
experiments: JT LL WC. Analyzed the data: HJB JT LL WC. Contributed
reagents/materials/analysis tools: HJB JT. Wrote the paper: HJB JT.
References
1. Imai S, Riley AL, Berne RM (1964) Effect of ischaemia on adenine nucleotides
in cardiac and skeletal muscle. Circ Res 15: 443–450.
2. Hellsten Y, Maclean D, Radegran G, Saltin B, Bangsbo J (1998) Adenosine
concentrations in the interstitium of resting and contracting human skeletal
muscle. Circ 98: 6–8.
3. Costa F, Heusinkveld J, Balog R, Davis S, Biaggioni I (2000) Estimation of
skeletal muscle adenosine during forearm dynamic exercise in humans.
Hypertens 35: 1124–1128.
4. Lo SM, Mo FM, Ballard HJ (2001) Interstitial adenosine concentration in rat red
or white muscle during systemic hypoxia or contractions. Exp Physiol 86: 593–
598.
5. Kille JM, Klabunde RE (1984) Adenosine as a mediator of postcontraction
hyperemia in dog gracilis muscle. Am J Physiol 246: H274–H282.
6. Proctor KG (1984) Reduction of contraction-induced arteriolar vasodilation by
adenosine deaminase or theophylline. Am J Physiol 247: H195–H205.
7. Ballard HJ, Cotterrell D, Karim F (1987) Appearance of adenosine in venous
blood from the contracting gracilis muscle and its role in vasodilation in the dog.
J Physiol 387: 401–413.
8. Poucher SM, Nowell CG, Collis MG (1990) The role of adenosine in exercise
hyperaemia of the gracilis muscle in anaesthetized cats. J Physiol 427: 19–29.
9. Cheng B, Essackjee HC, Ballard HJ (2000) Evidence for control of adenosine
metabolism in rat oxidative skeletal muscle by changes in pH. J Physiol 522:
467–477.
10. Lynge J, Juel C, Hellsten Y (2001) Extracellular formation and uptake of
adenosine during skeletal muscle contraction in the rat: role of adenosine
transporters. J Physiol 537: 597–605.
11. Mo FM, Ballard HJ (2001) The effect of systemic hypoxia on interstitial and
blood adenosine, AMP, ADP and ATP in dog skeletal muscle. J Physiol 536:
593–603.
12. Li J, King NC, Sinoway LI (2003) ATP concentrations and muscle tension
increase linearly with muscle contraction. J Appl Physiol 95: 577–583.
13. Burnstock G (2009) Purinergic signalling: past, present and future. Braz J Med
Biol Res 42: 3–8.
14. Rosenmeier JB, Hansen J, Gonza´lez-Alonso J (2004) Circulating ATP-induced
vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal
muscle. J Physiol 558: 351–365.
15. Mortensen SP, Gonzalez-Alonso J, Nielsen JJ, Saltin B, Hellsten Y (2009) Muscle
interstitial ATP and norepinephrine concentrations in the human leg during
exercise and ATP infusion. J Appl Physiol 107: 1757–1762.
16. Li J, Sinoway LI (2002) ATP stimulates chemically sensitive and sensitizes
mechanically sensitive afferents. Am J Physiol 283: H2636–H2643.
17. Tu J, Le GY, Ballard HJ (2010) Involvement of the cystic fibrosis
transmembrane conductance regulator in the acidosis-induced efflux of ATP
from rat skeletal muscle. J Physiol 588: 4563–4578.
18. Achike FI, Ballard HJ (1993) Influence of stimulation parameters on the release
of adenosine, lactate and CO2 from contracting dog gracilis muscle. J Physiol
463: 107–121.
19. Mo FM, Ballard HJ (2000) The effect of lactic acid on intracellular pH and
adenosine output from superfused rat soleus muscle fibres. Life Sci 67: 227–234.
20. Riordan JR (2008) CFTR function and prospects for therapy. Ann Rev Biochem
77: 701–726.
21. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, et al. (1993) The
multidrug resistance (mdr1) gene product functions as an ATP channel. Proc
Natl Acad Sci USA 90: 312–316.
22. Sugita M, Yue Y, Foskett JK (1998) CFTR chloride channel and CFTR-
associated ATP channel: distinct pores regulated by common gates. EMBO J 17:
898–908.
cAMP/PKA Regulates CFTR in ATP Release from Muscle
PLOS ONE | www.plosone.org 15 November 2012 | Volume 7 | Issue 11 | e50157
23. Taylor AL, Kudlow BA, Marrs KL, Gruenert DC, Guggino WB, et al. (1998)
Bioluminescence detection of ATP release mechanisms in epithelia. Am J Physiol
275: C1391–C1406.
24. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ (1998)
Deformation-induced ATP release from red blood cells requires CFTR activity.
Am J Physiol 275: H1726–H1732.
25. Braunstein GM, Romans RM, Clancy JP, Kudlow BA, Taylor AL, et al. (2001)
Cystic fibrosis transmembrane conductance regulator facilitates ATP release by
stimulating a separate ATP release channel for autocrine control of cell volume
regulation. J Biol Chem 276: 6621–6630.
26. Reisin IL, Prat AG, Abraham EH, Amara JF, Gregory RJ, et al. (1994) The
cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride
channel. J Biol Chem 269: 20584–20591.
27. Prat AG, Reisin IL, Ausiello DA, Cantiello HF (1996) Cellular ATP release by
the cystic fibrosis transmembrane conductance regulator. Am J Physiol 270:
C538–C545.
28. Cantiello HF, Jackson GR, Grosman CF, Prat AG, Borkan SC, et al. (1998)
Electrodiffusional ATP movement through the cystic fibrosis transmembrane
conductance regulator. Am J Physiol 274: C799–C809.
29. Reddy MM, Quinton PM, Haws C, Wine JJ, Grygorczyk R, et al. (1996) Failure
of the cystic fibrosis transmembrane conductance regulator to conduct ATP.
Science 271: 1876–1879.
30. Schweibert EM. (1999) ABC-transporter-facilitated ATP conductive transport.
Am J Physiol 276: C1–C8.
31. Marcaida G, Minana MD, Grisolia S, Felipo V (1997) Determination of
intracellular cAMP in primary cultures of neurones. Brain Res Protoc 1: 75–78.
32. Chang XB, Tabcharani JA, Hou YX, Jensen TJ, Kartner N, et al. (1993).
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis
of all ten PKA consensus phosphorylation sites. J Biol Chem 268: 11304–11311.
33. Houslay MD, Schafer P, Zhang KY (2005) Keynote review: phosphodiesterase-4
as a therapeutic target. Drug Discov Today 10: 1503–1519.
34. Pittner R, Beaumont K, Young A, Rink T (1995) Dose-dependent elevation of
cyclic AMP, activation of glycogen phosphorylase, and release of lactate by
amylin in rat skeletal muscle. Biochim Biophys Acta 1267: 75–82.
35. Lader AS, Wang Y, Jackson GR, Borkan SC, Cantiello HF (2000) cAMP-
activated anion conductance is associated with expression of CFTR in neonatal
mouse cardiac myocytes. Am J Physiol 278: C436–C450.
36. Lader AS, Xiao YF, O’Riordan CR, Prat AG, Jackson GR, et al. (2000) cAMP
activates an ATP-permeable pathway in rat neonatal cardiac myocytes.
Am J Physiol 279: C173–C187.
37. Chen JH, Cai ZW, Sheppard DN (2009) Direct sensing of intracellular pH by
the cystic fibrosis transmembrane conductance regulator Cl2 channel. J Biol
Chem 284: 35495–35506.
38. Sunahara RK, Taussig R (2002) Isoforms of mammalian adenyl cyclase:
multiplicities of signalling. Molecular Interventions 2: 168–184.
39. Cooper DMF, Mons N, Karpen JW (1995) Adenyl cyclases and the interaction
between calcium and cAMP signalling. Nature 374: 421–424.
40. Willoughby D, Cooper DMF (2007) Organisation and Ca2+ regulation of
adenylyl cyclases in cAMP microdomains. Physiol Rev 87: 965–1010.
41. Hanoune J, Defer N (2001) Regulation and role of adenylyl cyclase isoforms.
Annu Rev Pharmacol Toxicol 41: 145–74.
42. Tresguerres M, Levin LR, Buck J (2011) Intracellular cAMP signaling by soluble
adenylyl cyclase. Kidney Intl 79: 1277–1288.
43. Pittman N, Shue GL, LeLeiko NS, Walsh MJ (1995) Transcription of cystic
fibrosis transmembrane conductance regulator requires a CCAAT-like element
for both basal and cAMP-mediated regulation. J Biol Chem 270: 28848–28857.
44. Vuillamier S, Dixmeras I, Messai H, Lapoumeroulie C, Lallemand D, et al.
(1997) Cross-species characterization of the promoter region of the cystic fibrosis
transmembrane conductance regulator gene reveals multiple levels of regulation.
Biochem J 327: 651–662.
45. Aickin CC, Thomas RC (1977) An investigation of the ionic mechanism of
intracellular pH regulation in mouse soleus muscle fibres. J Physiol 273: 295–
316.
46. Aronson PS, Nee J, Suhm MA (1982) Modifier role of internal H+ in activating
the Na+-H+ exchanger in renal microvillus membrane vesicles. Nature 299: 161–
163.
47. Juel C (1986) Potassium and sodium shifts during isometric muscle contraction,
and the time course of the ion-gradient recovery. Pflugers Arch 406: 458–463.
48. Westerblad H, Lannergren J (1988) The relation between force and intracellular
pH in fatigued, single Xenopus muscle fibres. Acta Physiol Scand 133: 83–89.
49. Goshima K, Wakabayashi S (1981) Involvement of an Na+/Ca2+ exchange
system in genesis of ouabain-induced arrhythmias of cultured myocardial cells.
J Mol Cell Cardiol 13: 489–509.
50. Frelin C, Vigne P, Lazdunski M (1984) The role of the Na+/H+ exchange system
in cardiac cells in relation to the control of the internal Na+ concentration. J Biol
Chem 259: 8880–8885.
51. Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K (1999) The
myocardial Na+-H+ exchange: structure, regulation, and its role in heart disease.
Circ Res 85: 777–786.
52. Fraysse B, Rouaud T, Millour M, Fontaine-Perus J, Gardahaut MF, et al. (2001)
Expression of the Na+/Ca2+ exchanger in skeletal muscle. Am J Physiol 280:
C146–C154.
53. Ferreira JCB, Bacurau AV, Bueno CR, Cunha TC, Tanaka LY, et al. (2010)
Aerobic exercise training improves Ca2+ handling and redox status of skeletal
muscle in mice. Exp Biol Med 235: 497–505.
54. Germinario E, Esposito A, Midrio M, Peron S, Palade PT, et al. (2008) High
frequency fatigue of skeletal muscle: role of extracellular Ca2+. Eur J Appl
Physiol 104: 445–453.
55. Deval E, Raymond G, Cognard C (2002) Na+-Ca2+ exchange activity in rat
skeletal myotubes: effect of lithium ions. Cell Calcium 31: 37–44.
56. Cifuentes F, Vergara J, Hidalgo C (2000) Sodium/calcium exchange in
amphibian skeletal muscle fibers and isolated transverse tubules. Am J Physiol
279: C89–C97.
57. Iwata Y, Katanosaka Y, Hisamitsu T, Wakabayashi S (2007) Enhanced Na+/H+
exchange activity contributes to the pathogenesis of muscular dystrophy via
involvement of P2 receptors. Am J Pathol 171: 1576–1587.
58. Li JH, King NC, Sinoway LI (2005) Interstitial ATP and norepinephrine
concentrations in active muscle. Circ 111: 2748–2751.
59. Nishiyama A, Majid DSA, Taher KA, Miyatake A, Navar LG (2000) Relation
between renal interstitial ATP concentrations and autoregulation-mediated
changes in renal vascular resistance. Circ Res 86: 656–662.
60. Melani A, Turchi D, Vannuchi MG, Cipriani S, Gianfriddo M, et al. (2005)
ATP extracellular concentrations are increased in the rat striatum during in vivo
ischemia. Neurochem Intl 47: 442–448.
61. Shoubridge EA, Bland JL, Radda GK (1984) Regulation of creatine kinase
during steady-state isometric twitch contraction in rat skeletal muscle. Biochim
Biophys Acta 805: 72–78.
62. Challiss RA, Vranic M, Radda GK (1989) Bioenergetic changes during
contraction and recovery in diabetic rat skeletal muscle. Am J Physiol 256:
E129–E137.
63. Takata S, Ikata T (2001) Differences in energy metabolism and neuromuscular
transmission between 30-Hz and 100-Hz stimulation in rat skeletal muscle. Arch
Phys Med Rehabil 82: 666–670.
cAMP/PKA Regulates CFTR in ATP Release from Muscle
PLOS ONE | www.plosone.org 16 November 2012 | Volume 7 | Issue 11 | e50157
